Cargando…

Sensitivity and Specificity of a Novel Classifier for the Early Diagnosis of Dengue

BACKGROUND: Dengue is the commonest arboviral disease of humans. An early and accurate diagnosis of dengue can support clinical management, surveillance and disease control and is central to achieving the World Health Organisation target of a 50% reduction in dengue case mortality by 2020. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuan, Nguyen Minh, Nhan, Ho Thi, Chau, Nguyen Van Vinh, Hung, Nguyen Thanh, Tuan, Ha Manh, Tram, Ta Van, Ha, Nguyen Le Da, Loi, Phan, Quang, Han Khoi, Kien, Duong Thi Hue, Hubbard, Sonya, Chau, Tran Nguyen Bich, Wills, Bridget, Wolbers, Marcel, Simmons, Cameron P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383489/
https://www.ncbi.nlm.nih.gov/pubmed/25836753
http://dx.doi.org/10.1371/journal.pntd.0003638
Descripción
Sumario:BACKGROUND: Dengue is the commonest arboviral disease of humans. An early and accurate diagnosis of dengue can support clinical management, surveillance and disease control and is central to achieving the World Health Organisation target of a 50% reduction in dengue case mortality by 2020. METHODS: 5729 children with fever of <72hrs duration were enrolled into this multicenter prospective study in southern Vietnam between 2010-2012. A composite of gold standard diagnostic tests identified 1692 dengue cases. Using statistical methods, a novel Early Dengue Classifier (EDC) was developed that used patient age, white blood cell count and platelet count to discriminate dengue cases from non-dengue cases. RESULTS: The EDC had a sensitivity of 74.8% (95%CI: 73.0-76.8%) and specificity of 76.3% (95%CI: 75.2-77.6%) for the diagnosis of dengue. As an adjunctive test alongside NS1 rapid testing, sensitivity of the composite test was 91.6% (95%CI: 90.4-92.9%). CONCLUSIONS: We demonstrate that the early diagnosis of dengue can be enhanced beyond the current standard of care using a simple evidence-based algorithm. The results should support patient management and clinical trials of specific therapies.